New research uncovers mechanisms behind heart damage from CTLA-4 blockade

Cytotoxic T-lymphocyte antigen 4 (CTLA-4) is a protein receptor on T immune cells that prevents the cells from killing other cells, such as cancer cells.

Spell Check-Up: Prove Your Spelling Proficiency

Welcome to Spell Check-Up, a game where your medical spelling skills are put to the test. We give you the definition of a healthcare-related word

July 6, 2023

Long-term immune changes persist in unvaccinated COVID-19 patients

Study reveals that unvaccinated individuals experience significant long-term changes in immune parameters up to ten months post-COVID-19 infection, with a shift towards a Th2 cytokine

July 22, 2024

Morgan Health, JP Morgan’s healthcare venture, is looking to cut pharma costs next

(This story is from our new Health Tech newsletter. If you’d like to sign up, just click here.) Morgan Health, the health venture JP Morgan

March 20, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.